{"result": {"id": "761b7cc5-3817-44e4-aa00-ea56717468c2", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"N Engl J Med and Cardiovascular Research Community\",\n    \"summary\": \"This community is centered around the *New England Journal of Medicine (N Engl J Med)*, a prestigious medical journal that publishes significant research on cardiovascular diseases, treatments, and prevention strategies. The journal serves as a hub for researchers and studies, connecting entities through publications and collaborations. Key entities include researchers like Yusuf S, RAY KK, and FLINT AC, who have contributed to groundbreaking studies published in the journal. The community's focus on cardiovascular research highlights its importance in advancing medical science and improving patient outcomes.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's significant contributions to cardiovascular research and its potential to influence medical practices and policies worldwide.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central Role of N Engl J Med\",\n            \"explanation\": \"The *New England Journal of Medicine* is the cornerstone of this community, publishing high-impact research on cardiovascular diseases and treatments. Its rigorous peer-review process and wide readership make it a critical platform for disseminating medical knowledge. The journal's relationships with researchers and studies underscore its pivotal role in the community. [Data: Entities (2352), Relationships (3634, 3154, 4496, 3335, 3406, +more)]\"\n        },\n        {\n            \"summary\": \"Key Researchers and Their Contributions\",\n            \"explanation\": \"Researchers such as Yusuf S, RAY KK, and FLINT AC have made significant contributions to cardiovascular research, with their studies published in *N Engl J Med*. Their work spans various aspects of cardiovascular disease, from prevention to treatment, highlighting the community's diverse expertise. [Data: Entities (2995, 4647, 3178), Relationships (3472, 4496, 3335)]\"\n        },\n        {\n            \"summary\": \"Focus on Cardiovascular Disease Prevention and Treatment\",\n            \"explanation\": \"The community's research emphasizes both the prevention and treatment of cardiovascular diseases, including studies on lipid-modulating therapies, blood pressure control, and novel treatments like tirzepatide. This dual focus ensures a comprehensive approach to tackling cardiovascular health issues. [Data: Entities (3589, 2301), Relationships (3600, 3601, 3602)]\"\n        },\n        {\n            \"summary\": \"Collaborative Research Efforts\",\n            \"explanation\": \"Collaborations among researchers, such as those between Yusuf S and Lonn E or between Zhao D and Wang M, demonstrate the community's collaborative spirit. These partnerships enhance the quality and impact of the research produced. [Data: Relationships (3136, 2570)]\"\n        },\n        {\n            \"summary\": \"Global Impact of Research\",\n            \"explanation\": \"Studies like the INTERHEART study, led by Yusuf S, have a global reach, analyzing risk factors for myocardial infarction across 52 countries. Such research underscores the community's ability to address cardiovascular health on a worldwide scale. [Data: Entities (3348), Relationships (3472)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560525, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 654, "prompt_tokens": 4906, "total_tokens": 5560, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 3434}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3589,TIRZEPATIDE,,4\n2352,N ENGL J MED,\"The *New England Journal of Medicine (N Engl J Med)* is a highly respected and prestigious international medical journal known for publishing original research, clinical trial reports, and reviews on a wide range of medical topics. It has featured significant studies on hypertension, including its effects on systolic and diastolic blood pressure, treatments, and associated cardiovascular events. The journal has also published research on preeclampsia in pregnancy, blood pressure control and renal failure in children, and novel therapies such as volanesorsen for triglyceride levels in familial chylomicronemia syndrome and evinacumab for homozygous familial hypercholesterolemia. Additionally, it has covered studies on tirzepatide and bariatric surgery outcomes, as well as phase 3 trials of inclisiran. Renowned for its rigorous peer-review process and influential contributions to medical science, *N Engl J Med* remains a leading source of cutting-edge clinical and research findings.\",23\n3012,BOWMAN L,A researcher studying the effects of aspirin in primary prevention for diabetes patients,3\n4647,RAY KK,\"**RAY KK** is a researcher known for their significant contributions to the field of cardiovascular disease prevention, particularly in the development and evaluation of lipid-modulating therapies. They led phase 3 clinical trials for **inclisiran**, a novel therapy targeting **LDL cholesterol** reduction. Additionally, RAY KK has been involved in the review of emerging lipid-modulating treatments, further solidifying their expertise in advancing cardiovascular therapeutics. Their work underscores a commitment to improving outcomes in cardiovascular disease through innovative research and clinical trials.\",2\n3178,FLINT AC,\"Author of a study on the effect of systolic and diastolic blood pressure on cardiovascular outcomes, published in N Engl J Med in 2019\"\"\",1\n3284,ESCAPE TRIALGROUP,\"The ESCAPE Trial Group conducted a study on strict blood pressure control and progression of renal failure in children\"\"\",1\n3327,ROLNIK DL,,1\n3317,TITA AT,\"Researcher investigating treatment for mild chronic hypertension during pregnancy\"\"\",1\n4699,RAAL FJ,\"Researcher involved in the study of evinacumab for homozygous familial hypercholesterolemia\"\"\",1\n4700,ROSENSON RS,\"Researcher involved in the study of evinacumab for homozygous familial hypercholesterolemia\"\"\",1\n4701,REESKAMP LF,\"Researcher involved in the study of evinacumab for homozygous familial hypercholesterolemia\"\"\",1\n4702,WITZTUM JL,\"Researcher involved in the study of volanesorsen and triglyceride levels in familial chylomicronemia syndrome\"\"\",1\n4703,GAUDET D,\"Researcher involved in the study of volanesorsen and triglyceride levels in familial chylomicronemia syndrome\"\"\",1\n4704,FREEDMAN SD,\"Researcher involved in the study of volanesorsen and triglyceride levels in familial chylomicronemia syndrome\"\"\",1\n2995,YUSUF S,\"Yusuf S is a prominent researcher known for his extensive contributions to cardiovascular studies. He serves as the principal investigator of the HOPE study and has been involved in research on atrial fibrillation treatment. Additionally, Yusuf S has participated in the INTERHEART study, which focuses on identifying risk factors for myocardial infarction. His work also includes investigating the effects of blood-pressure and cholesterol-lowering treatments in individuals without pre-existing cardiovascular disease. Collectively, his research spans multiple critical areas of cardiology, emphasizing prevention, risk assessment, and therapeutic interventions.\",7\n2996,LONN E,Lonn E is a researcher involved in studying blood-pressure and cholesterol lowering in persons without cardiovascular disease,2\n2997,PAIS P,Pais P is a researcher involved in studying blood-pressure and cholesterol lowering in persons without cardiovascular disease,2\n2999,DANS A,Dans A is a researcher involved in studying polypill with or without aspirin in persons without cardiovascular disease,2\n3348,INTERHEART STUDY,\"A case-control study analyzing modifiable risk factors for myocardial infarction across 52 countries\"\"\",2\n3435,HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS,Research group studying cardiovascular event prevention>,1\n2301,NAT REV CARDIOL,\"**NAT REV CARDIOL** (*Nature Reviews Cardiology*) is a medical journal specializing in comprehensive reviews on cardiovascular topics. It has published significant studies, including an epidemiology study on cardiovascular disease in China, as well as a review of novel lipid-modulating therapies for cardiovascular disease prevention. The journal serves as a key resource for research and advancements in the field of cardiology.\",4\n2315,ZHAO D,\"A researcher involved in epidemiology studies on cardiovascular disease in China\"\"\",2\n2336,WANG M,\"WANG M is a researcher specializing in epidemiology, with a focus on cardiovascular disease studies in China. Notably, WANG M has contributed to research on coronary heart disease risk prediction, particularly in individuals who snore and have hypertension. As an author, WANG M has been involved in studies examining the relationship between snoring, hypertension, and the likelihood of developing coronary heart disease. Their work underscores their expertise in cardiovascular epidemiology and risk assessment in high-risk populations.\",3\n3292,BROWN MA,\"Brown MA is one of the authors of a study on hypertensive disorders of pregnancy and their classification, diagnosis, and management recommendations\"\"\",2\n3293,MAGEE LA,\"Magee LA is a researcher specializing in hypertensive disorders during pregnancy, with a focus on conditions such as preeclampsia. As one of the authors of a study on hypertensive disorders of pregnancy, Margee LA has contributed to the classification, diagnosis, and management recommendations for these conditions. Their work emphasizes improving hypertension control in pregnancy, particularly in addressing the complexities of preeclampsia. Overall, Margee LA's research plays a significant role in advancing understanding and clinical approaches to pregnancy-related hypertension.\",3\n3294,KENNYLC,\"KennyLC is one of the authors of a study on hypertensive disorders of pregnancy and their classification, diagnosis, and management recommendations\"\"\",2\n3553,JASTREBOFFAM,JastreboffAM is a researcher involved in the study of tirzepatide for obesity treatment,1\n3554,ARONNELJ,AronneLJ is a researcher involved in the study of tirzepatide for obesity treatment,1\n3555,AHMADNN,AhmadNN is a researcher involved in the study of tirzepatide for obesity treatment,1\n4631,ADHYARU BB,\"Researcher who studied safety and efficacy of statin therapy\"\"\",1\n4709,BRANDTS J,\"Researcher involved in the review of novel lipid-modulating therapies for cardiovascular disease prevention\"\"\",1\n2998,JOSEPH P,Joseph P is a researcher involved in studying polypill with or without aspirin in persons without cardiovascular disease,2\n3028,MAFHAM M,Researcher studying aspirin effects in diabetes patients,1\n3029,WALLENDSZUS K,Researcher studying aspirin effects in diabetes patients,1\n3015,MCNEIL JJ,A researcher studying the effects of aspirin on cardiovascular events in the elderly,3\n3034,WOLFE R,Researcher studying aspirin effects in elderly patients,1\n3035,WOODS RL,Researcher studying aspirin effects in elderly patients,1\n3020,CONNOLLY SJ,A researcher involved in studies comparing dabigatran and warfarin in atrial fibrillation patients,3\n3044,EZEKOWITZ MD,Researcher involved in atrial fibrillation treatment studies,1\n3021,PATEL MR,A researcher involved in studies comparing rivaroxaban and warfarin in atrial fibrillation patients,3\n3045,MAHAFFEY KW,Researcher involved in atrial fibrillation treatment studies,1\n3046,GARG J,Researcher involved in atrial fibrillation treatment studies,1\n3698,WANG MH,\"WANG MH is a researcher and author known for their work on prognostic models, particularly focusing on high-risk patients. They have contributed to a study that developed a prognostic model specifically for high-risk coronary heart disease patients, with an emphasis on snorers who also have uncontrolled hypertension. Their research aims to improve risk assessment and clinical outcomes for this patient population.\",1\n3708,RISK MANAG HEALTHC POLICY,\"Journal publishing healthcare risk management research\"\"\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3634,TIRZEPATIDE,N ENGL J MED,Tirzepatide obesity treatment study was published in NEJM,27\n3154,N ENGL J MED,BOWMAN L,Published research on aspirin for primary prevention in diabetes patients in N Engl J Med,26\n4496,RAY KK,N ENGL J MED,Ray KK's inclisiran trials were published in NEJM,25\n3335,FLINT AC,N ENGL J MED,Flint AC's study was published in N Engl J Med,24\n3406,ESCAPE TRIALGROUP,N ENGL J MED,The ESCAPE Trial Group published their study in this journal,24\n3423,N ENGL J MED,ROLNIK DL,Published research on aspirin use in high-risk pregnancies in this journal,24\n3425,N ENGL J MED,TITA AT,Published research on chronic hypertension treatment during pregnancy in this journal,24\n4536,RAAL FJ,N ENGL J MED,Raal FJ was a researcher in a study published in N Engl J Med,24\n4537,ROSENSON RS,N ENGL J MED,Rosenson RS was a researcher in a study published in N Engl J Med,24\n4538,REESKAMP LF,N ENGL J MED,Reeskamp LF was a researcher in a study published in N Engl J Med,24\n4539,N ENGL J MED,WITZTUM JL,Witztum JL was a researcher in a study published in N Engl J Med,24\n4540,N ENGL J MED,GAUDET D,Gaudet D was a researcher in a study published in N Engl J Med,24\n4541,N ENGL J MED,FREEDMAN SD,Freedman SD was a researcher in a study published in N Engl J Med,24\n3136,YUSUF S,LONN E,Yusuf S and Lonn E collaborated on research about blood-pressure and cholesterol lowering in persons without cardiovascular disease,9\n3137,YUSUF S,PAIS P,Yusuf S and Pais P collaborated on research about blood-pressure and cholesterol lowering in persons without cardiovascular disease,9\n3139,YUSUF S,DANS A,Yusuf S and Dans A collaborated on research about polypill with or without aspirin in persons without cardiovascular disease,9\n3472,INTERHEART STUDY,YUSUF S,Led the INTERHEART study on myocardial infarction,9\n3525,HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS,YUSUF S,Led the landmark HOPE trial,8\n2549,NAT REV CARDIOL,ZHAO D,Zhao D co-authored an epidemiology study published in Nat Rev Cardiol,6\n2570,ZHAO D,WANG M,Zhao D and Wang M co-authored an epidemiology study on cardiovascular disease,5\n3411,BROWN MA,MAGEE LA,Brown MA and Magee LA co-authored a study on hypertensive disorders of pregnancy,5\n3413,MAGEE LA,KENNYLC,Magee LA and KennyLC co-authored a study on hypertensive disorders of pregnancy,5\n3600,JASTREBOFFAM,TIRZEPATIDE,JastreboffAM is a researcher involved in the study of tirzepatide for obesity treatment,5\n3601,ARONNELJ,TIRZEPATIDE,AronneLJ is a researcher involved in the study of tirzepatide for obesity treatment,5\n3602,AHMADNN,TIRZEPATIDE,AhmadNN is a researcher involved in the study of tirzepatide for obesity treatment,5\n4481,NAT REV CARDIOL,ADHYARU BB,Adhyaru BB published research in Nature Reviews Cardiology,5\n4548,BRANDTS J,NAT REV CARDIOL,Brandts J was a researcher in a study published in Nat Rev Cardiol,5\n3140,LONN E,PAIS P,Lonn E and Pais P collaborated on research about blood-pressure and cholesterol lowering in persons without cardiovascular disease,4\n3141,JOSEPH P,DANS A,Joseph P and Dans A collaborated on research about polypill with or without aspirin in persons without cardiovascular disease,4\n3166,BOWMAN L,MAFHAM M,Co-authors on aspirin study in diabetes patients,4\n3167,BOWMAN L,WALLENDSZUS K,Co-authors on aspirin study in diabetes patients,4\n3172,MCNEIL JJ,WOLFE R,Co-authors on aspirin study in elderly patients,4\n3173,MCNEIL JJ,WOODS RL,Co-authors on aspirin study in elderly patients,4\n3184,CONNOLLY SJ,EZEKOWITZ MD,Co-authors on atrial fibrillation treatment study,4\n3186,PATEL MR,MAHAFFEY KW,Co-authors on atrial fibrillation treatment study,4\n3187,PATEL MR,GARG J,Co-authors on atrial fibrillation treatment study,4\n3412,BROWN MA,KENNYLC,Brown MA and KennyLC co-authored a study on hypertensive disorders of pregnancy,4\n3736,WANG M,WANG MH,Co-authors of studies on prognostic models for high-risk patients,4\n3737,WANG M,RISK MANAG HEALTHC POLICY,Published research in this journal,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_7d3b1fdfd63558884a580767e3f143df268cba6723aad9df6969ba92a2908b09_v2"}